Global ophthalmology drugs market to hit $26.28b by 2030

Investments, strategic collaborations, and therapy advancements drive growth.

The global ophthalmology drugs market, valued at $19.52b, is projected to hit $26.28b by 2030 at a compound annual growth rate of 6.1%, according to a MarketsandMarkets report.

The sector’s expansion is attributed to a growing population affected by eye conditions and a strong pipeline of drugs in development for ophthalmology indications.

Moreover, increasing investments and strategic collaborations, along with advancements in therapy development, are driving the market.

“However, challenges such as the off-label use of medications and non-adherence to intravitreal injection treatments may restrain market growth during the forecast period,” the report said.